Complete metabolic remission in an 84-year old patient with relapsed/refractory diffuse large B-cell lymphoma following combination immunotherapy with lenalidomide plus rituximab.

Complete metabolic remission in an 84-year old patient with relapsed/refractory diffuse large B-cell lymphoma following combination immunotherapy with lenalidomide plus rituximab. Int J Hematol. 2020 Sep 04;: Authors: Tomuleasa C, Iluta S, Pasca S, Roman A, Piciu D, Jitaru C, Teodorescu P, Rus I, Bojan A, Dima D, Zdrenghea M, Petrushev B PMID: 32886277 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32886277?dopt=Abstract

Source: International Journal of Hematology - September 3, 2020 Category: Hematology Authors: Tomuleasa C, Iluta S, Pasca S, Roman A, Piciu D, Jitaru C, Teodorescu P, Rus I, Bojan A, Dima D, Zdrenghea M, Petrushev B Tags: Int J Hematol Source Type: research

More News: Hematology | Immunotherapy | Lymphoma | Revlimid | Rituxan